Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE1946.4585.1 (+4.57 %)

PREV CLOSE ( ) 1861.35

OPEN PRICE ( ) 1869.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2830

TODAY'S LOW / HIGH ( )1869.00 2057.75

52 WK LOW / HIGH ( )1246.75 3375.45

NSE1941.8080.8 (+4.34 %)

PREV CLOSE( ) 1861.00

OPEN PRICE ( ) 1851.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1941.80 (5)

VOLUME 30292

TODAY'S LOW / HIGH( ) 1849.80 2070.00

52 WK LOW / HIGH ( )1242.95 3379

Chairman	Bhupendra Gandhi
Managing Director	Rajiv Gandhi
Company Secretary	Vinod Mali
Executive Director	Priya Gandhi
Alternate Director	Nina Gandhi
Promoter & Non-Executive Director	Sanjiv Gandhi Ravin Gandhi
Non Executive Independent Director	Sandhya Patel Ashok Bhadakal Ameet Desai Anil Jain Jatin Trivedi

Incorporation Year : 1987

Registered Office :

Address : Meda Adraj , Kadi, , Mehsana,
Gujarat-384441 .

Phone : 079 – 26445106

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE